You are here


OptogeniX develops, produces and sells new technologies to deliver light into the brain with revolutionary versatility and minimized invasiveness, overcoming the limitation of biomedical devices currently available on the market.
The company is a spin-off of the research activities performed in collaboration between the Center for Biomolecular Nanotechnologies of the Istituto Italiano di Tecnologia (IIT, Lecce - Italy) and the Department of Neurobiology at Harvard Medical School (Boston, USA).
OptogeniX headquarters are in the neighborhoods of Lecce (Italy), one of the most important district in Italy for R&D on nanotechnologies.